AVCNF (AVCNF) Stock Price & Analysis
AVCNF (AVCNF) rose 4.17% to USD 0.1 as of July 25, 2026 at 09:17 UTC, according to Nexqual real-time market data.
AVCNF last closed at USD 0.1; the session ranged USD 0.1–0.1 on volume of 20,000 shares. Market capitalization is $12.58M, with a 52-week range of USD 0.07–0.24 (OQX). Source: Nexqual, July 25, 2026 at 09:17 UTC.
Key Statistics (as of July 25, 2026 at 09:17 UTC)
| Price | USD 0.1 |
|---|---|
| Change | ▲ 4.17% (up) |
| Previous Close | USD 0.1 |
| Open | USD 0.1 |
| Day Range | USD 0.1 – 0.1 |
| 52-Week Range | USD 0.07 – 0.24 |
| Volume | 20,000 shares |
| Market Cap | $12.58M |
| Exchange | OQX |
Technical Analysis (AVCNF)
Nexqual's technical model rates AVCNF "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 09:17 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.9 (neutral) |
| vs SMA50 | Above (USD 0.09) |
| MACD | 0 (positive) |
Analyst Ratings (AVCNF)
Wall Street analysts rate AVCNF "None", per Nexqual as of July 25, 2026 at 09:17 UTC.
| Consensus Rating | None |
|---|
Earnings (AVCNF)
| Next Earnings Date | 2026-08-12 |
|---|
Source: Nexqual, July 25, 2026 at 09:17 UTC.
Financials & Fundamentals (AVCNF)
| Total Revenue | $25.83M |
|---|---|
| Revenue Growth (YoY) | +5.60% |
| Gross Margin | +53.24% |
| Operating Margin | -4.63% |
| Profit Margin | -12.09% |
| ROE | -26.45% |
| Current Ratio | 0.96 |
| Total Cash | $372,103 |
| Total Debt | $0 |
| Free Cash Flow | $-1.39M |
Source: Nexqual, July 25, 2026 at 09:17 UTC.
Financial Health Score (AVCNF)
Nexqual rates AVCNF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 09:17 UTC.
| Growth | Solid — Revenue +6% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $372K cash, no debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -26%, ROA -9.3% |
Ownership (AVCNF)
| Insider Ownership | +22.59% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 125.79M |
| Float | 109.95M |
Source: Nexqual, July 25, 2026 at 09:17 UTC.
Leadership (AVCNF)
AVCNF is led by Aras Azadian B.Econ, Co-Founder, CEO & Director, per Nexqual as of July 25, 2026 at 09:17 UTC.
| Co-Founder, CEO & Director | Aras Azadian B.Econ |
|---|---|
| Chief Financial Officer | Nick Hilborn C.A. |
| Executive Vice President of Marketing | Ivana Maric |
| Executive Vice President of Scientific & Medical Affairs | Karolina Urban |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROMJF | Rubicon Organics Inc. | USD 0.34 | ▲ 4.36% |
| BBRRF | Blueberries Medical Co. | USD 0.01 | ▲ 0% |
| BMMJ | Body and Mind Inc. | USD 0 | ▲ 0% |
| DBCCF | Decibel Cannabis Co Inc. | USD 0.08 | ▲ 0.65% |
| FFNTF | 4Front Ventures Corp. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:17 UTC. This page is informational and not investment advice.